インターベンショナルラジオロジー（IVR）の世界市場予測（～2021年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKET COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 SECONDARY DATA 18
2.1.1 KEY DATA FROM SECONDARY SOURCES 18
2.2 PRIMARY DATA 19
2.2.1 KEY DATA FROM PRIMARY SOURCES 20
2.3 MARKET SIZE ESTIMATION 21
2.3.1 BOTTOM-UP APPROACH 21
2.3.2 TOP-DOWN APPROACH 22
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 23
2.5 ASSUMPTIONS FOR THE STUDY 24

3 EXECUTIVE SUMMARY 25
3.1 INTRODUCTION 25
3.2 CONCLUSION 29

4 PREMIUM INSIGHTS 30
4.1 INTERVENTIONAL RADIOLOGY: MARKET OVERVIEW 30
4.2 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT AND REGION (2016) 31
4.3 LIFE CYCLE ANALYSIS, BY REGION 32

5 INDUSTRY INSIGHTS 33
5.1 INTRODUCTION 33
5.2 PORTER’S FIVE FORCES ANALYSIS 34
5.2.1 THREAT OF NEW ENTRANTS 35
5.2.2 THREAT OF SUBSTITUTES 35
5.2.3 BARGAINING POWER OF BUYERS 35
5.2.4 BARGAINING POWER OF SUPPLIERS 35
5.2.5 INTENSITY OF RIVALRY 36
 
5.3 SUPPLY CHAIN ANALYSIS 36
5.4 KEY INFLUENCERS 37

6 MARKET OVERVIEW 38
6.1 INTRODUCTION 39
6.2 MARKET DYNAMICS 39
6.2.1 DRIVERS 40
6.2.1.1 Rising incidence and prevalence of chronic diseases 40
6.2.1.2 Increasing demand for minimally invasive procedures 41
6.2.1.3 Technological advancements in Interventional Radiology devices 41
6.2.2 RESTRAINTS 42
6.2.2.1 Risk of high radiation exposure to limit the use of CT scanners 42
6.2.2.2 Shortage of Helium – a major concern for MRI manufacturers and healthcare facilities 42
6.2.3 OPPORTUNITIES 43
6.2.3.1 Emerging markets 43
6.2.4 CHALLENGES 44
6.2.4.1 Entry barriers for new players 44
6.2.4.2 Hospital budget cuts 44
6.2.4.3 Increasing adoption of refurbished Interventional Radiology systems 45

7 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT 46
7.1 INTRODUCTION 47
7.2 MRI SYSTEMS 49
7.3 ULTRASOUND IMAGING SYSTEMS 50
7.4 CT SCANNERS 51
7.5 ANGIOGRAPHY SYSTEMS 52
7.6 FLUOROSCOPY SYSTEMS 53
7.7 BIOPSY DEVICES 54
7.8 OTHER DEVICES 55

8 INTERVENTIONAL RADIOLOGY MARKET, BY PROCEDURE 56
8.1 INTRODUCTION 57
8.2 ANGIOGRAPHY 58
8.3 ANGIOPLASTY 59
8.4 BIOPSY AND DRAINAGE 60
8.5 EMBOLIZATION 61
8.6 THROMBOLYSIS 62
8.7 VERTEBROPLASTY 63
8.8 NEPHROSTOMY 64
8.9 OTHER PROCEDURES 65
 

9 INTERVENTIONAL RADIOLOGY MARKET, BY APPLICATION 66
9.1 INTRODUCTION 67
9.2 CARDIOLOGY 68
9.3 UROLOGY & NEPHROLOGY 69
9.4 ONCOLOGY 70
9.5 GASTROENTEROLOGY 72
9.6 OTHER APPLICATIONS 73

10 INTERVENTIONAL RADIOLOGY MARKET, BY REGION 74
10.1 INTRODUCTION 75
10.2 NORTH AMERICA 76
10.2.1 U.S. 80
10.2.2 CANADA 82
10.3 EUROPE 85
10.3.1 GERMANY 88
10.3.2 FRANCE 91
10.3.3 U.K. 93
10.3.4 ITALY 95
10.3.5 REST OF EUROPE 97
10.4 ASIA 99
10.5 REST OF THE WORLD (ROW) 104

11 COMPETITIVE LANDSCAPE 108
11.1 OVERVIEW 108
11.2 MARKET SHARE ANALYSIS 109
11.3 COMPETITIVE SITUATION AND TRENDS 110
11.3.1 PRODUCT LAUNCHES 111
11.3.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS 112
11.3.3 APPROVALS 113
11.3.4 EXPANSIONS 114
11.3.5 ACQUISITIONS 114
11.3.6 OTHER DEVELOPMENTS 115

12 COMPANY PROFILE 116
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION 116
12.2 GE HEALTHCARE (A FULLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 117
12.3 SIEMENS AG 121
12.4 KONINKLIJKE PHILIPS N.V. 126
12.5 TOSHIBA MEDICAL SYSTEMS CORPORATION (TOSHIBA CORPORATION) 130
12.6 HITACHI MEDICAL CORPORATION (HITACHI LTD.) 134
12.7 CARESTREAM HEALTH 137
12.8 ESAOTE S.P.A. 139
12.9 HOLOGIC INC. 141
12.10 SHIMADZU CORPORATION 143
12.11 SAMSUNG MEDISON 145
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13 APPENDIX 147
13.1 INDUSTRY INSIGHTS 147
13.2 DISCUSSION GUIDE 148
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 152
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 154
13.5 AVAILABLE CUSTOMIZATIONS 155
13.6 RELATED REPORTS 156
13.7 AUTHOR DETAILS 157